• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Recombinant human erythropoietin (rhEPO) in the prevention and treatment of chemotherapy-induced anaemia.

作者信息

Nowrousian M R

出版信息

Med Oncol. 1998 Sep;15(3):141-4. doi: 10.1007/BF02821932.

DOI:10.1007/BF02821932
PMID:9819790
Abstract
摘要

相似文献

1
Recombinant human erythropoietin (rhEPO) in the prevention and treatment of chemotherapy-induced anaemia.重组人促红细胞生成素（rhEPO）在预防和治疗化疗所致贫血中的应用
Med Oncol. 1998 Sep;15(3):141-4. doi: 10.1007/BF02821932.
2
Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients with ovarian carcinoma treated with platinum-based chemotherapy.皮下注射重组人促红细胞生成素对铂类化疗的卵巢癌患者贫血及输血依赖性影响的对照多中心研究。
Med Oncol. 1998 Sep;15(3):174-82. doi: 10.1007/BF02821936.
3
What is the role of erythropoietin in patients with solid tumours?促红细胞生成素在实体瘤患者中起什么作用？
Ann Oncol. 1998 Mar;9(3):239-41. doi: 10.1023/a:1008273032715.
4
[Use of erythropoietin in the treatment of cancer-related anemia].促红细胞生成素在癌症相关性贫血治疗中的应用
Zhonghua Zhong Liu Za Zhi. 2011 Nov;33(11):877-8.
5
Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours.重组人促红细胞生成素治疗实体瘤患者癌症相关或化疗所致贫血
Med Oncol. 1998 Aug;15 Suppl 1:S19-28.
6
Management of chemotherapy-induced anemia.化疗所致贫血的管理
Curr Opin Oncol. 1995 Jul;7(4):316-9. doi: 10.1097/00001622-199507000-00004.
7
Erythropoietin for anaemia in cancer patients.促红细胞生成素用于治疗癌症患者的贫血
Eur J Cancer. 1993;29A Suppl 2:S2-8. doi: 10.1016/s0959-8049(05)80281-3.
8
Recombinant human erythropoietin in the treatment of cancer-related anaemia.重组人促红细胞生成素治疗癌症相关性贫血
Eur J Haematol. 1997 Apr;58(4):251-6. doi: 10.1111/j.1600-0609.1997.tb01663.x.
9
Erythropoietin therapy in cancer patients.
Oncology (Williston Park). 1991 Aug;5(8):31-7; discussion 38, 43-4.
10
Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: a randomized, controlled study.重组人促红细胞生成素治疗化疗所致贫血及预防实体瘤相关输血需求：一项随机对照研究。
Ann Oncol. 1998 Mar;9(3):255-60. doi: 10.1023/a:1008296622469.

本文引用的文献

1
Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients with ovarian carcinoma treated with platinum-based chemotherapy.皮下注射重组人促红细胞生成素对铂类化疗的卵巢癌患者贫血及输血依赖性影响的对照多中心研究。
Med Oncol. 1998 Sep;15(3):174-82. doi: 10.1007/BF02821936.
2
Allogeneic transfusion and infection: economic and clinical implications.异体输血与感染：经济及临床影响
Semin Hematol. 1997 Jul;34(3 Suppl 2):34-40.
3
Randomized phase III trial evaluating the role of erythropoietin in the prevention of chemotherapy-induced anemia.
评估促红细胞生成素在预防化疗所致贫血中作用的随机III期试验。
J Clin Oncol. 1997 Jul;15(7):2715-21. doi: 10.1200/JCO.1997.15.7.2715.
4
Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group.社区肿瘤实践中癌症化疗期间使用阿法依泊汀治疗对非髓系恶性肿瘤患者临床结局的影响。促红细胞生成素研究组。
J Clin Oncol. 1997 Mar;15(3):1218-34. doi: 10.1200/JCO.1997.15.3.1218.
5
The transfusion immunomodulation theory: the Th1/Th2 paradigm and an analogy with pregnancy as a unifying mechanism.
Semin Hematol. 1996 Oct;33(4):329-40.
6
Transfusion-transmitted infections: update.输血传播感染：最新进展
Semin Hematol. 1996 Oct;33(4):290-301.
7
Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma--a randomized multicenter study. The European Study Group of Erythropoietin (Epoetin Beta) Treatment in Multiple Myeloma and Non-Hodgkin's Lymphoma.重组人促红细胞生成素用于多发性骨髓瘤和非霍奇金淋巴瘤输血依赖型贫血患者——一项随机多中心研究。欧洲促红细胞生成素（β-促红细胞生成素）治疗多发性骨髓瘤和非霍奇金淋巴瘤研究组
Blood. 1996 Apr 1;87(7):2675-82.
8
Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.重组人促红细胞生成素用于纠正癌症相关贫血，无论是否同时进行细胞毒性化疗。
Cancer. 1995 Dec 1;76(11):2319-29. doi: 10.1002/1097-0142(19951201)76:11<2319::aid-cncr2820761121>3.0.co;2-u.
9
Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response.重组人促红细胞生成素治疗多发性骨髓瘤或非霍奇金淋巴瘤相关贫血：剂量探索及反应预测因素的识别
Blood. 1995 Dec 15;86(12):4446-53.
10
The frequency of red cell transfusion for anemia in patients receiving chemotherapy. A retrospective cohort study.化疗患者中因贫血进行红细胞输血的频率。一项回顾性队列研究。
Am J Clin Oncol. 1993 Feb;16(1):22-5. doi: 10.1097/00000421-199302000-00006.